What is NDC 65862-884?

65862-884 is the product NDC for Minocycline Hydrochloride, Minocycline hydrochloride 80 mg/1 tablet, film coated, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Minocycline Hydrochloride?

124 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Minocycline Hydrochloride NDC 65862-884

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-884Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0884Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-884-01	65862088401	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-884-01)Marketed from Jun 13, 2016
65862-884-05	65862088405	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-884-05)Marketed from Jun 13, 2016
65862-884-30	65862088430	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-884-30)Marketed from Jun 13, 2016
65862-884-99	65862088499	1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-884-99)Marketed from Jun 13, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Minocycline Hydrochloride
Generic name (nonproprietary): minocycline hydrochloride
Active ingredients: Minocycline hydrochloride — 80 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202261
Marketing start: Jun 13, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Prothrombin Activity (Physiologic effect)Tetracyclines (Chemical structure)
Identifiers: Product ID 65862-884_5569f0f6-b36f-4149-aee7-2699fa5ebe53SPL ID 5569f0f6-b36f-4149-aee7-2699fa5ebe53SPL set ID e7b88a48-12b3-461d-b356-0d7ae4e8fd44RxCUI 629695, 629697, 629699, 858062, 858372, 1013659, 1013662, 1013665UNII 0020414E5UUPC 0365862555304
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862088401 followed by a unit qualifier and the quantity

Package 65862-0884-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 11, 2025.

Indications (excerpt from the label)

Minocycline hydrochloride extended-release tablets are indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies (14) ]. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated [see Warnings and Precautions (5.12) ] . Minocycline hydrochloride is …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-884

What is NDC 65862-884?: 65862-884 is the product NDC for Minocycline Hydrochloride, Minocycline hydrochloride 80 mg/1 tablet, film coated, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Minocycline Hydrochloride.
What is the active ingredient?: Minocycline hydrochloride.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Minocycline Hydrochloride?: 124 other product NDCs are listed under this name. See all Minocycline Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Minocycline Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Minocycline Hydrochloride	Minocycline hydrochloride 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4565	70518-4565-00
minocycline hydrochloride	Minocycline hydrochloride 65 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-532	68382-0532-0168382-0532-0568382-0532-06+3 more
minocycline hydrochloride	Minocycline hydrochloride 115 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-534	68382-0534-0168382-0534-0568382-0534-06+3 more
minocycline hydrochloride	Minocycline hydrochloride 55 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-550	68382-0550-0168382-0550-0568382-0550-06+3 more
minocycline hydrochloride	Minocycline hydrochloride 55 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1153	70771-1153-0070771-1153-0170771-1153-03+3 more
minocycline hydrochloride	Minocycline hydrochloride 65 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1154	70771-1154-0070771-1154-0170771-1154-03+3 more
minocycline hydrochloride	Minocycline hydrochloride 115 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1158	70771-1158-0070771-1158-0170771-1158-03+3 more
Minocycline Hydrochloride	Minocycline hydrochloride 100 mg/1	CapsuleOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0390	80425-0390-0180425-0390-0280425-0390-03
Minocycline hydrochloride	Minocycline hydrochloride 100 mg/1	CapsuleOral	Northwind Health Company, LLC	82868-017	82868-0017-60
Minocycline hydrochloride	Minocycline hydrochloride 100 mg/1	CapsuleOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0314	80425-0314-0180425-0314-0280425-0314-03

All 125 Minocycline Hydrochloride NDCs

Other NDCs under ANDA 202261

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202261
Product	Strength	Form · route	Labeler	Product NDC
Minocycline Hydrochloride	Minocycline hydrochloride 105 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-885
Minocycline Hydrochloride	Minocycline hydrochloride 55 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-883
Minocycline Hydrochloride	Minocycline hydrochloride 45 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-554
Minocycline Hydrochloride	Minocycline hydrochloride 135 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-558
Minocycline Hydrochloride	Minocycline hydrochloride 65 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-555
Minocycline Hydrochloride	Minocycline hydrochloride 90 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-556
Minocycline Hydrochloride	Minocycline hydrochloride 115 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-557